STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
IDRA IDERA PHARMACEUTICALS INCORPORATED StockScouter® Report
2
StockScouter® Score
IDERA PHARMACEUTICALS INCORPORATED, a micro cap company in the healthcare sector, is expected to underperform the market over the next six months with higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
Concerns
- The enterprise value-to-sales ratio is much higher than the average for comparably-sized companies in the StockScouter universe. Very Negative
- Moving average analysis for IDRA suggests downward price movement over the medium term. Negative
- Shares are being sold by financial institutions. Slightly negative for a small company like IDRA
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be in favor, stocks will be , and healthcare stocks will be in favor.
Expected Risk/Return
Core Model Grades
C
C
F
C